Bradbury Funding Invest 
socalTECH
NOVEMBER 18, 2014
San Diego-based Renova Therapeutics , a biopharmaceuticals company developing treatments for congestive heart failure and other diseases, has raised $7.52M in a Series C funding round. The company said the funding primarily came from high net worth individuals. As part of the funding, Daniel M.
socalTECH
MAY 4, 2020
in a Series A funding round, to go towards its products. According to Alume, the funding came from angel investors, including co-founder Chrysa Mineo (formerly of Receptos and Neurocrine Biosciences) and Dan Bradbury (co-founder and Executive Chairman of Equillium, Inc. and former CEO of Amylin).
Expert insights. Personalized for you.
138 
Let's personalize your content